The 2007 Breast Cancer Symposium Press Briefing featured three abstracts highlighting research on the racial differences in the biology of breast cancer, the association between treatment adherence and a patient’s risk of death, and significant side effects associated with a growing class of breast cancer drugs.

Studies included:

• An analysis of racial differences in rates of estrogen receptor-negative (ER-negative) breast cancer finding that black women are more likely than white women to have this form of aggressive, difficult-to-treat breast cancer.
  
  
• A large retrospective study showing that women who take less than 70 percent of their tamoxifen prescriptions are at increased risk of death.
  
  
• A multicenter study finding that breast cancer drugs in the aromatase inhibitors class are associated with musculoskeletal side effects that result in 13 percent of women discontinuing their therapy.
  

Select the link below to access the audio and slide presentation of the press briefing.

2007 Breast Cancer Symposium Webcast

2007 Breast Cancer Symposium Webcast (Version for Mac users)

If you are having trouble viewing the presentation, please visit www.asco.org/vmhelp or send an e-mail to webrequest@asco.org.